Complement-based Therapies for Geographic Atrophy (GA)

Opinion
Video

Murtaza Adam, MD, opens a discussion surrounding complement therapies for patients diagnosed with geographic atrophy.

Newsletter

Keep your retina practice on the forefront—subscribe for expert analysis and emerging trends in retinal disease management.

Subscribe Now!
Recent Videos
1 expert in this video
Related Content
ASRS 2025: Underfunding of Good Days program affect on patients and practices

ASRS 2025: Underfunding of Good Days program affect on patients and practices

Michael Lai, MD, PhD;Martin David Harp;Sydney M Crago
August 8th 2025
Article
ASRS 2025: PER-001 improved structure and visual function in patients with diabetic retinopathy

ASRS 2025: PER-001 improved structure and visual function in patients with diabetic retinopathy

Justis Ehlers, MD, FASRS
August 8th 2025
Article
ASRS 2025: An analysis of patients who received pegcetacoplan and anti-VEGF for GA

ASRS 2025: An analysis of patients who received pegcetacoplan and anti-VEGF for GA

Nimesh A. Patel, MD;Martin David Harp;Sydney M Crago
August 8th 2025
Article
ASRS 2025: An association of vitamin D insufficiency with proliferative vitreoretinopathy

ASRS 2025: An association of vitamin D insufficiency with proliferative vitreoretinopathy

Steven D. Ness, MD;Sydney M Crago;Martin David Harp
August 8th 2025
Article
(Image credit: Modern Retina) CTS 2025: Christine Kay, MD, on OPGx LCA5 clinical results translated into real-life changes

CTS 2025: Christine Kay, MD, on OPGx-LCA5 clinical results translated into real-life changes

Christine N. Kay, MD;Sheryl Stevenson
August 8th 2025
Article
Geographic atrophy treatment: High attrition rates challenge long-term patient adherence

Geographic atrophy treatment: High attrition rates challenge long-term patient adherence

Deepak Sambhara, MD;Sydney M Crago
August 8th 2025
Article
© 2025 MJH Life Sciences

All rights reserved.